Structure

Physi-Chem Properties

Molecular Weight:  486.26
Volume:  492.491
LogP:  2.577
LogD:  2.354
LogS:  -4.345
# Rotatable Bonds:  3
TPSA:  113.43
# H-Bond Aceptor:  7
# H-Bond Donor:  2
# Rings:  6
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.466
Synthetic Accessibility Score:  5.921
Fsp3:  0.821
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.221
MDCK Permeability:  1.6034018699428998e-05
Pgp-inhibitor:  0.89
Pgp-substrate:  0.987
Human Intestinal Absorption (HIA):  0.007
20% Bioavailability (F20%):  0.06
30% Bioavailability (F30%):  0.937

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.804
Plasma Protein Binding (PPB):  59.815704345703125%
Volume Distribution (VD):  0.466
Pgp-substrate:  16.71221160888672%

ADMET: Metabolism

CYP1A2-inhibitor:  0.016
CYP1A2-substrate:  0.642
CYP2C19-inhibitor:  0.046
CYP2C19-substrate:  0.836
CYP2C9-inhibitor:  0.032
CYP2C9-substrate:  0.028
CYP2D6-inhibitor:  0.003
CYP2D6-substrate:  0.078
CYP3A4-inhibitor:  0.757
CYP3A4-substrate:  0.918

ADMET: Excretion

Clearance (CL):  13.343
Half-life (T1/2):  0.807

ADMET: Toxicity

hERG Blockers:  0.094
Human Hepatotoxicity (H-HT):  0.249
Drug-inuced Liver Injury (DILI):  0.373
AMES Toxicity:  0.091
Rat Oral Acute Toxicity:  0.604
Maximum Recommended Daily Dose:  0.798
Skin Sensitization:  0.782
Carcinogencity:  0.774
Eye Corrosion:  0.014
Eye Irritation:  0.076
Respiratory Toxicity:  0.961

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC264954

Natural Product ID:  NPC264954
Common Name*:   HLZVPWRVYKJCMY-ZHLLBWASSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  HLZVPWRVYKJCMY-ZHLLBWASSA-N
Standard InCHI:  InChI=1S/C28H38O7/c1-14-11-20(34-24(32)17(14)13-29)15(2)27(33)10-8-18-16-12-23-28(35-23)22(31)6-5-21(30)26(28,4)19(16)7-9-25(18,27)3/h5-6,15-16,18-20,22-23,29,31,33H,7-13H2,1-4H3/t15-,16+,18+,19+,20-,22+,23-,25+,26+,27+,28-/m1/s1
SMILES:  OCC1=C(C)C[C@@H](OC1=O)[C@H]([C@@]1(O)CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2C[C@@H]2[C@]3([C@]1(C)C(=O)C=C[C@@H]3O)O2)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2047414
PubChem CID:   12147447
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000258] Steroids and steroid derivatives
        • [CHEMONTID:0001125] Steroid lactones
          • [CHEMONTID:0001560] Withanolides and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO20281 Withania aristata Species Solanaceae Eukaryota n.a. n.a. n.a. PMID[22705001]
NPO20281 Withania aristata Species Solanaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT165 Cell Line HeLa Homo sapiens IC50 = 17700.0 nM PMID[482740]
NPT81 Cell Line A549 Homo sapiens IC50 > 40000.0 nM PMID[482740]
NPT165 Cell Line HeLa Homo sapiens IC50 = 19800.0 nM PMID[482740]
NPT81 Cell Line A549 Homo sapiens IC50 = 31700.0 nM PMID[482740]
NPT83 Cell Line MCF7 Homo sapiens IC50 = 16300.0 nM PMID[482740]
NPT83 Cell Line MCF7 Homo sapiens IC50 = 10300.0 nM PMID[482740]
NPT189 Cell Line Vero Chlorocebus aethiops IC50 = 28800.0 nM PMID[482740]
NPT189 Cell Line Vero Chlorocebus aethiops IC50 = 21800.0 nM PMID[482740]
NPT189 Cell Line Vero Chlorocebus aethiops Ratio IC50 = 1.8 n.a. PMID[482740]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC264954 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9909 High Similarity NPC474370
0.9817 High Similarity NPC167606
0.9817 High Similarity NPC286528
0.9817 High Similarity NPC20302
0.9817 High Similarity NPC140055
0.9817 High Similarity NPC470492
0.9732 High Similarity NPC88326
0.9732 High Similarity NPC153700
0.9727 High Similarity NPC50774
0.9727 High Similarity NPC709
0.9636 High Similarity NPC470493
0.9636 High Similarity NPC312824
0.9636 High Similarity NPC183580
0.9561 High Similarity NPC8374
0.9541 High Similarity NPC122056
0.9469 High Similarity NPC470878
0.9469 High Similarity NPC67569
0.9469 High Similarity NPC473256
0.9455 High Similarity NPC67259
0.9455 High Similarity NPC147912
0.9386 High Similarity NPC470265
0.9386 High Similarity NPC23786
0.9375 High Similarity NPC186525
0.9375 High Similarity NPC329736
0.9304 High Similarity NPC469789
0.9292 High Similarity NPC473274
0.9292 High Similarity NPC61520
0.9273 High Similarity NPC191620
0.9224 High Similarity NPC470494
0.9224 High Similarity NPC3381
0.9224 High Similarity NPC172154
0.9224 High Similarity NPC8369
0.9224 High Similarity NPC81736
0.9196 High Similarity NPC270929
0.9145 High Similarity NPC293112
0.9138 High Similarity NPC11895
0.9123 High Similarity NPC473270
0.9115 High Similarity NPC243065
0.9052 High Similarity NPC170538
0.9027 High Similarity NPC64318
0.9009 High Similarity NPC470961
0.9009 High Similarity NPC474315
0.8966 High Similarity NPC46570
0.8938 High Similarity NPC284915
0.8919 High Similarity NPC29133
0.8917 High Similarity NPC473593
0.8889 High Similarity NPC269642
0.8889 High Similarity NPC107493
0.8824 High Similarity NPC473635
0.8818 High Similarity NPC91034
0.8814 High Similarity NPC204812
0.8793 High Similarity NPC475041
0.8783 High Similarity NPC470959
0.8783 High Similarity NPC476965
0.877 High Similarity NPC231240
0.8761 High Similarity NPC476163
0.875 High Similarity NPC287423
0.875 High Similarity NPC37116
0.875 High Similarity NPC473253
0.8739 High Similarity NPC241456
0.8739 High Similarity NPC32868
0.8707 High Similarity NPC311554
0.8707 High Similarity NPC257457
0.8699 High Similarity NPC316915
0.8661 High Similarity NPC475065
0.8649 High Similarity NPC330011
0.8649 High Similarity NPC329048
0.8632 High Similarity NPC476960
0.8632 High Similarity NPC475520
0.8621 High Similarity NPC471854
0.8607 High Similarity NPC231529
0.8607 High Similarity NPC470880
0.8596 High Similarity NPC69291
0.8596 High Similarity NPC236217
0.8595 High Similarity NPC156797
0.8571 High Similarity NPC475418
0.8571 High Similarity NPC318363
0.8571 High Similarity NPC472825
0.8571 High Similarity NPC473482
0.8559 High Similarity NPC79579
0.8559 High Similarity NPC476961
0.8559 High Similarity NPC268530
0.8559 High Similarity NPC154491
0.8547 High Similarity NPC153440
0.8537 High Similarity NPC220757
0.8537 High Similarity NPC196921
0.8534 High Similarity NPC190286
0.8509 High Similarity NPC470960
0.85 High Similarity NPC120724
0.85 High Similarity NPC473979
0.8496 Intermediate Similarity NPC474901
0.8496 Intermediate Similarity NPC475941
0.8487 Intermediate Similarity NPC4021
0.8487 Intermediate Similarity NPC159456
0.8482 Intermediate Similarity NPC473284
0.8475 Intermediate Similarity NPC5292
0.8475 Intermediate Similarity NPC42673
0.8475 Intermediate Similarity NPC473203
0.8462 Intermediate Similarity NPC239273
0.8455 Intermediate Similarity NPC476966
0.8455 Intermediate Similarity NPC35109
0.8443 Intermediate Similarity NPC470882
0.8443 Intermediate Similarity NPC473265
0.8435 Intermediate Similarity NPC475970
0.8435 Intermediate Similarity NPC475524
0.8435 Intermediate Similarity NPC100267
0.843 Intermediate Similarity NPC469790
0.8421 Intermediate Similarity NPC473627
0.8407 Intermediate Similarity NPC220155
0.8403 Intermediate Similarity NPC476962
0.8403 Intermediate Similarity NPC251226
0.8403 Intermediate Similarity NPC474585
0.84 Intermediate Similarity NPC469673
0.839 Intermediate Similarity NPC473720
0.8378 Intermediate Similarity NPC475050
0.8376 Intermediate Similarity NPC148458
0.8376 Intermediate Similarity NPC176840
0.8376 Intermediate Similarity NPC470075
0.8374 Intermediate Similarity NPC473620
0.8364 Intermediate Similarity NPC476897
0.8362 Intermediate Similarity NPC317210
0.8362 Intermediate Similarity NPC250109
0.8361 Intermediate Similarity NPC159499
0.8347 Intermediate Similarity NPC6193
0.8333 Intermediate Similarity NPC476823
0.8333 Intermediate Similarity NPC472216
0.8333 Intermediate Similarity NPC214644
0.8333 Intermediate Similarity NPC173905
0.8333 Intermediate Similarity NPC5475
0.8333 Intermediate Similarity NPC284828
0.832 Intermediate Similarity NPC34963
0.8319 Intermediate Similarity NPC305260
0.8319 Intermediate Similarity NPC144459
0.8319 Intermediate Similarity NPC270850
0.8319 Intermediate Similarity NPC230513
0.8306 Intermediate Similarity NPC471407
0.8305 Intermediate Similarity NPC185287
0.8305 Intermediate Similarity NPC55296
0.8305 Intermediate Similarity NPC469684
0.8291 Intermediate Similarity NPC474181
0.8276 Intermediate Similarity NPC269530
0.8273 Intermediate Similarity NPC474012
0.8273 Intermediate Similarity NPC476299
0.8261 Intermediate Similarity NPC76084
0.8261 Intermediate Similarity NPC16270
0.8257 Intermediate Similarity NPC253826
0.8254 Intermediate Similarity NPC58029
0.8246 Intermediate Similarity NPC177064
0.824 Intermediate Similarity NPC173347
0.824 Intermediate Similarity NPC241935
0.824 Intermediate Similarity NPC279478
0.8235 Intermediate Similarity NPC146786
0.8235 Intermediate Similarity NPC475372
0.8235 Intermediate Similarity NPC113448
0.823 Intermediate Similarity NPC266570
0.823 Intermediate Similarity NPC60681
0.8226 Intermediate Similarity NPC311534
0.8214 Intermediate Similarity NPC297617
0.8214 Intermediate Similarity NPC112009
0.8214 Intermediate Similarity NPC72151
0.8214 Intermediate Similarity NPC329345
0.8214 Intermediate Similarity NPC473283
0.8214 Intermediate Similarity NPC476237
0.8214 Intermediate Similarity NPC475526
0.8214 Intermediate Similarity NPC26478
0.8211 Intermediate Similarity NPC203702
0.8211 Intermediate Similarity NPC15095
0.8211 Intermediate Similarity NPC120994
0.8205 Intermediate Similarity NPC962
0.8205 Intermediate Similarity NPC25909
0.8198 Intermediate Similarity NPC282524
0.819 Intermediate Similarity NPC317107
0.819 Intermediate Similarity NPC470076
0.8182 Intermediate Similarity NPC316598
0.8182 Intermediate Similarity NPC98868
0.8182 Intermediate Similarity NPC470418
0.8182 Intermediate Similarity NPC124512
0.8182 Intermediate Similarity NPC310511
0.8182 Intermediate Similarity NPC159763
0.8182 Intermediate Similarity NPC478056
0.8182 Intermediate Similarity NPC312481
0.8182 Intermediate Similarity NPC278386
0.8175 Intermediate Similarity NPC471855
0.8174 Intermediate Similarity NPC87335
0.8174 Intermediate Similarity NPC41405
0.8167 Intermediate Similarity NPC312536
0.8167 Intermediate Similarity NPC470495
0.8167 Intermediate Similarity NPC278681
0.816 Intermediate Similarity NPC221414
0.8158 Intermediate Similarity NPC67321
0.8158 Intermediate Similarity NPC131665
0.8158 Intermediate Similarity NPC255387
0.8158 Intermediate Similarity NPC475294
0.8158 Intermediate Similarity NPC301666
0.8158 Intermediate Similarity NPC79298
0.8158 Intermediate Similarity NPC43063
0.8158 Intermediate Similarity NPC187435
0.8151 Intermediate Similarity NPC157380
0.8151 Intermediate Similarity NPC284068
0.8151 Intermediate Similarity NPC473656

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC264954 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9817 High Similarity NPD7115 Discovery
0.8182 Intermediate Similarity NPD4225 Approved
0.812 Intermediate Similarity NPD8297 Approved
0.8087 Intermediate Similarity NPD6881 Approved
0.8087 Intermediate Similarity NPD6899 Approved
0.8034 Intermediate Similarity NPD6649 Approved
0.8034 Intermediate Similarity NPD6650 Approved
0.8 Intermediate Similarity NPD5697 Approved
0.7951 Intermediate Similarity NPD6319 Approved
0.7949 Intermediate Similarity NPD7290 Approved
0.7949 Intermediate Similarity NPD7102 Approved
0.7949 Intermediate Similarity NPD6883 Approved
0.7913 Intermediate Similarity NPD6675 Approved
0.7913 Intermediate Similarity NPD6402 Approved
0.7913 Intermediate Similarity NPD7128 Approved
0.7913 Intermediate Similarity NPD5739 Approved
0.7881 Intermediate Similarity NPD6869 Approved
0.7881 Intermediate Similarity NPD6617 Approved
0.7881 Intermediate Similarity NPD6847 Approved
0.7881 Intermediate Similarity NPD8130 Phase 1
0.7863 Intermediate Similarity NPD6372 Approved
0.7863 Intermediate Similarity NPD6012 Approved
0.7863 Intermediate Similarity NPD6014 Approved
0.7863 Intermediate Similarity NPD6013 Approved
0.7863 Intermediate Similarity NPD6373 Approved
0.7815 Intermediate Similarity NPD6882 Approved
0.7807 Intermediate Similarity NPD5211 Phase 2
0.7788 Intermediate Similarity NPD7640 Approved
0.7788 Intermediate Similarity NPD7639 Approved
0.7778 Intermediate Similarity NPD7320 Approved
0.7778 Intermediate Similarity NPD6011 Approved
0.7768 Intermediate Similarity NPD6083 Phase 2
0.7768 Intermediate Similarity NPD6084 Phase 2
0.775 Intermediate Similarity NPD4632 Approved
0.7734 Intermediate Similarity NPD7319 Approved
0.7706 Intermediate Similarity NPD5785 Approved
0.7699 Intermediate Similarity NPD7638 Approved
0.7698 Intermediate Similarity NPD7492 Approved
0.7692 Intermediate Similarity NPD5701 Approved
0.7672 Intermediate Similarity NPD5141 Approved
0.7661 Intermediate Similarity NPD6054 Approved
0.7656 Intermediate Similarity NPD7736 Approved
0.7647 Intermediate Similarity NPD6371 Approved
0.7647 Intermediate Similarity NPD4634 Approved
0.7638 Intermediate Similarity NPD6616 Approved
0.7638 Intermediate Similarity NPD7507 Approved
0.7632 Intermediate Similarity NPD5286 Approved
0.7632 Intermediate Similarity NPD4696 Approved
0.7632 Intermediate Similarity NPD5285 Approved
0.7607 Intermediate Similarity NPD6008 Approved
0.76 Intermediate Similarity NPD7503 Approved
0.7589 Intermediate Similarity NPD6356 Clinical (unspecified phase)
0.7578 Intermediate Similarity NPD7078 Approved
0.7568 Intermediate Similarity NPD6399 Phase 3
0.7563 Intermediate Similarity NPD4061 Clinical (unspecified phase)
0.7544 Intermediate Similarity NPD5696 Approved
0.754 Intermediate Similarity NPD6370 Approved
0.75 Intermediate Similarity NPD5225 Approved
0.75 Intermediate Similarity NPD4633 Approved
0.75 Intermediate Similarity NPD5226 Approved
0.75 Intermediate Similarity NPD5224 Approved
0.748 Intermediate Similarity NPD7604 Phase 2
0.7477 Intermediate Similarity NPD6079 Approved
0.746 Intermediate Similarity NPD6015 Approved
0.746 Intermediate Similarity NPD6016 Approved
0.7456 Intermediate Similarity NPD4755 Approved
0.744 Intermediate Similarity NPD7101 Approved
0.744 Intermediate Similarity NPD7100 Approved
0.7438 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.7436 Intermediate Similarity NPD5174 Approved
0.7436 Intermediate Similarity NPD5175 Approved
0.7434 Intermediate Similarity NPD4629 Approved
0.7434 Intermediate Similarity NPD5695 Phase 3
0.7434 Intermediate Similarity NPD5210 Approved
0.7419 Intermediate Similarity NPD6009 Approved
0.7414 Intermediate Similarity NPD5223 Approved
0.7411 Intermediate Similarity NPD4202 Approved
0.7402 Intermediate Similarity NPD5988 Approved
0.7395 Intermediate Similarity NPD6412 Phase 2
0.7381 Intermediate Similarity NPD6059 Approved
0.7364 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.736 Intermediate Similarity NPD6335 Approved
0.736 Intermediate Similarity NPD7328 Approved
0.736 Intermediate Similarity NPD7327 Approved
0.7355 Intermediate Similarity NPD5955 Clinical (unspecified phase)
0.7345 Intermediate Similarity NPD7748 Approved
0.7339 Intermediate Similarity NPD7521 Approved
0.7339 Intermediate Similarity NPD7334 Approved
0.7339 Intermediate Similarity NPD5330 Approved
0.7339 Intermediate Similarity NPD7146 Approved
0.7339 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.7339 Intermediate Similarity NPD6409 Approved
0.7339 Intermediate Similarity NPD3618 Phase 1
0.7339 Intermediate Similarity NPD6274 Approved
0.7339 Intermediate Similarity NPD6684 Approved
0.7328 Intermediate Similarity NPD4700 Approved
0.7323 Intermediate Similarity NPD5983 Phase 2
0.7323 Intermediate Similarity NPD8033 Approved
0.7321 Intermediate Similarity NPD7515 Phase 2
0.7321 Intermediate Similarity NPD5693 Phase 1
0.7308 Intermediate Similarity NPD8293 Discontinued
0.7304 Intermediate Similarity NPD7902 Approved
0.7302 Intermediate Similarity NPD7516 Approved
0.7297 Intermediate Similarity NPD4753 Phase 2
0.7297 Intermediate Similarity NPD5328 Approved
0.728 Intermediate Similarity NPD6317 Approved
0.7248 Intermediate Similarity NPD5363 Approved
0.7244 Intermediate Similarity NPD8294 Approved
0.7244 Intermediate Similarity NPD8377 Approved
0.7236 Intermediate Similarity NPD6053 Discontinued
0.7231 Intermediate Similarity NPD6336 Discontinued
0.7222 Intermediate Similarity NPD6313 Approved
0.7222 Intermediate Similarity NPD6314 Approved
0.7217 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.7217 Intermediate Similarity NPD5221 Approved
0.7217 Intermediate Similarity NPD5222 Approved
0.7207 Intermediate Similarity NPD6903 Approved
0.7203 Intermediate Similarity NPD7632 Discontinued
0.7193 Intermediate Similarity NPD6001 Approved
0.719 Intermediate Similarity NPD6686 Approved
0.719 Intermediate Similarity NPD5345 Clinical (unspecified phase)
0.719 Intermediate Similarity NPD4730 Approved
0.719 Intermediate Similarity NPD4729 Approved
0.7188 Intermediate Similarity NPD6291 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD8379 Approved
0.7188 Intermediate Similarity NPD8335 Approved
0.7188 Intermediate Similarity NPD8378 Approved
0.7188 Intermediate Similarity NPD8380 Approved
0.7188 Intermediate Similarity NPD8296 Approved
0.7168 Intermediate Similarity NPD5284 Approved
0.7168 Intermediate Similarity NPD5281 Approved
0.7156 Intermediate Similarity NPD3666 Approved
0.7156 Intermediate Similarity NPD3133 Approved
0.7156 Intermediate Similarity NPD4786 Approved
0.7156 Intermediate Similarity NPD3665 Phase 1
0.7155 Intermediate Similarity NPD5173 Approved
0.7143 Intermediate Similarity NPD6673 Approved
0.7143 Intermediate Similarity NPD6904 Approved
0.7143 Intermediate Similarity NPD6080 Approved
0.7119 Intermediate Similarity NPD5344 Discontinued
0.7107 Intermediate Similarity NPD5954 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD1694 Approved
0.7073 Intermediate Similarity NPD5251 Approved
0.7073 Intermediate Similarity NPD5250 Approved
0.7073 Intermediate Similarity NPD5248 Approved
0.7073 Intermediate Similarity NPD5249 Phase 3
0.7073 Intermediate Similarity NPD5247 Approved
0.7069 Intermediate Similarity NPD4697 Phase 3
0.7063 Intermediate Similarity NPD6868 Approved
0.7054 Intermediate Similarity NPD8513 Phase 3
0.7054 Intermediate Similarity NPD6908 Approved
0.7054 Intermediate Similarity NPD6909 Approved
0.7054 Intermediate Similarity NPD6672 Approved
0.7054 Intermediate Similarity NPD5737 Approved
0.7049 Intermediate Similarity NPD5128 Approved
0.7043 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7043 Intermediate Similarity NPD7900 Approved
0.7025 Intermediate Similarity NPD4768 Approved
0.7025 Intermediate Similarity NPD4767 Approved
0.7018 Intermediate Similarity NPD8035 Phase 2
0.7018 Intermediate Similarity NPD7637 Suspended
0.7018 Intermediate Similarity NPD8034 Phase 2
0.7016 Intermediate Similarity NPD5217 Approved
0.7016 Intermediate Similarity NPD5216 Approved
0.7016 Intermediate Similarity NPD5215 Approved
0.7 Intermediate Similarity NPD4754 Approved
0.6991 Remote Similarity NPD6051 Approved
0.6972 Remote Similarity NPD4269 Approved
0.6972 Remote Similarity NPD4223 Phase 3
0.6972 Remote Similarity NPD4221 Approved
0.6972 Remote Similarity NPD4270 Approved
0.6972 Remote Similarity NPD3667 Approved
0.6967 Remote Similarity NPD7899 Clinical (unspecified phase)
0.6964 Remote Similarity NPD3573 Approved
0.6947 Remote Similarity NPD8328 Phase 3
0.6937 Remote Similarity NPD5329 Approved
0.6937 Remote Similarity NPD7520 Clinical (unspecified phase)
0.6935 Remote Similarity NPD5169 Approved
0.6935 Remote Similarity NPD5135 Approved
0.6935 Remote Similarity NPD5134 Clinical (unspecified phase)
0.693 Remote Similarity NPD5207 Approved
0.6923 Remote Similarity NPD8516 Approved
0.6923 Remote Similarity NPD8517 Approved
0.6923 Remote Similarity NPD8515 Approved
0.6905 Remote Similarity NPD8133 Approved
0.6903 Remote Similarity NPD5208 Approved
0.6881 Remote Similarity NPD5369 Approved
0.688 Remote Similarity NPD5127 Approved
0.6875 Remote Similarity NPD6098 Approved
0.6875 Remote Similarity NPD5690 Phase 2
0.6875 Remote Similarity NPD5786 Approved
0.687 Remote Similarity NPD5694 Approved
0.687 Remote Similarity NPD6411 Approved
0.687 Remote Similarity NPD6050 Approved
0.6866 Remote Similarity NPD6033 Approved
0.6847 Remote Similarity NPD4197 Approved
0.6838 Remote Similarity NPD1698 Clinical (unspecified phase)
0.6833 Remote Similarity NPD4159 Approved
0.6818 Remote Similarity NPD4752 Clinical (unspecified phase)
0.681 Remote Similarity NPD5778 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data